跳至主要内容
临床试验/CTRI/2026/03/106149
CTRI/2026/03/106149尚未招募不适用

A Randomized Controlled Trial to evaluate the efficacy of Tejovatyadi Gutika Mukha-Dharan and Khadiradi Gutika Mukha-Dharan in Galagraha.

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2026年4月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
66
试验地点
1
主要终点
Symptoms like Kantha-shopha (Oedema of Oro-pharynx), Kantha-kandu (Itching in Oro-pharynx), Aaraktata (Congestion of posterior pharyngeal wall) will be decreased

研究概览

简要总结

Galagraha described in Ayurveda is a throat disorder characterized by pain, irritation, inflammation, and difficulty in swallowing, which clinically resembles acute pharyngitis. Mukha-Dharan (holding medicated formulations in the oral cavity) is an important local therapeutic procedure used in the management of throat diseases. Tejovatyadi Gutika and Khadiradi Gutika are classical Ayurvedic formulations known for their anti-inflammatory, antimicrobial, and soothing properties and are commonly used in throat disorders.

The present study is planned as a randomized controlled clinical trial to evaluate and compare the efficacy of Tejovatyadi Gutika Mukha-Dharan and Khadiradi Gutika Mukha-Dharan in the management of Galagraha. Patients fulfilling the diagnostic criteria will be randomly divided into two groups and treated with the respective interventions. Clinical parameters such as throat pain, dysphagia, irritation, and congestion will be assessed before and after treatment. The results will be analyzed statistically to determine the effectiveness of both therapies and their comparative efficacy in relieving the symptoms of Galagraha.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patients of age group 19 to 60 years, irrespective of their gender, religion, occupation and socio-economic status.
  • •All patients having signs and symptoms of Galagraha as follows i.
  • •Kantha-shopha (Oedema of Oro-pharynx) ii.
  • •Kantha-kandu (Itching in Oro-pharynx) iii.
  • •Aaraktata (Congestion of posterior pharyngeal wall).

排除标准

  • •Patients having moderate to high grade fever, having body temperature of greater than 100F.
  • •Patients suffering from complications like para-tonsillar abscess (quinsy), parapharyngeal abscess and other deep neck space infections.
  • •Patients diagnosed with malignancies of pharynx and oral cavity or systemic illness like Tuberculosis and other lower respiratory tract infections.

结局指标

主要结局

Symptoms like Kantha-shopha (Oedema of Oro-pharynx), Kantha-kandu (Itching in Oro-pharynx), Aaraktata (Congestion of posterior pharyngeal wall) will be decreased

时间窗: Follow up on 3rd and 7th day. Observational follow up on 14th day.

次要结局

未报告次要终点

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Piyush Manoj Aloni

MAMs Sumatibhai Shah Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验